about
Membranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.Complement component c1q and anti-c1q antibodies in theory and in clinical practice.Cutaneous lesions and finger clubbing uncovering hypocomplementemic urticarial vasculitis and hepatitis C with mixed cryoglobulinemia.The role of humoral innate immunity in hepatitis C virus infection.Rheumatoid factor, complement, and mixed cryoglobulinemia.Vasculitis secondary to anti-C1q antibodies induced by Toxocariasis.Anti-C1q autoantibodies, novel tests, and clinical consequences.Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions.Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.Zika virus infection elicits auto-antibodies to C1q.Anti-C1q in systemic lupus erythematosus.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.
P2860
Q34128722-F1642CAA-9919-4BC9-B26C-7291CFC2584AQ36231193-1BED6F1E-3578-470C-B60A-41A3EA776877Q37117977-388D5E0D-6CFE-44B9-BB83-B7C898384B4AQ37509470-AA4AA600-DABE-4D27-B636-28318C6083BFQ37987129-056B8006-BA76-4799-8695-6FF52FC94EA8Q38041549-024EF24E-9D63-4D22-9C12-C9E326808057Q40163743-12BFF2EB-C016-4BEC-9A6D-62819C3103BEQ40674285-74B5C607-16BF-4C74-8399-2BA094B74D0FQ42206002-169B6315-EF5C-4A68-AFBF-200198A5C605Q43041102-9F4FC5A2-56A9-47AD-9603-DFF8F8A69A9DQ43268549-73B67874-A284-454B-9E3C-D21141431E13Q44659110-2F7496CC-5072-45B9-8155-03D7D7F06608Q46666806-68787C09-8D9C-498E-821C-DA6363938C9DQ47547783-114CA90A-711D-4258-B42E-B18DCFC0B790Q51724933-E69F3846-AB28-47CF-BBF8-E8CD7419FD27Q55027429-DB222451-7247-4966-B3E3-32FE1495D455Q55130392-EF123B20-3A0E-4371-A88A-91AAE43EABB2
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Anti-C1q antibodies in hepatitis C virus infection
@ast
Anti-C1q antibodies in hepatitis C virus infection
@en
Anti-C1q antibodies in hepatitis C virus infection
@nl
type
label
Anti-C1q antibodies in hepatitis C virus infection
@ast
Anti-C1q antibodies in hepatitis C virus infection
@en
Anti-C1q antibodies in hepatitis C virus infection
@nl
prefLabel
Anti-C1q antibodies in hepatitis C virus infection
@ast
Anti-C1q antibodies in hepatitis C virus infection
@en
Anti-C1q antibodies in hepatitis C virus infection
@nl
P2093
P2860
P1476
Anti-C1q antibodies in hepatitis C virus infection
@en
P2093
J A Schifferli
M Trendelenburg
S Sadallah
P2860
P304
P356
10.1111/J.1365-2249.2006.03153.X
P577
2006-08-01T00:00:00Z